CTGF knockout does not affect cardiac hypertrophy and fibrosis formation upon chronic pressure overload

被引:39
|
作者
Fontes, Magda S. C. [1 ]
Kessler, Elise L. [1 ]
van Stuijvenberg, Leonie [1 ]
Brans, Maike A. [1 ]
Falke, Lucas L. [2 ]
Kok, Bart [1 ]
Leask, Andrew [3 ]
van Rijen, Harold V. M. [1 ]
Vos, Marc A. [1 ]
Goldschmeding, Roel [2 ]
van Veen, Toon A. B. [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Med Physiol, Div Heart & Lungs, Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands
[3] Univ Western Ontario, Dept Dent, London, ON N6A 3K7, Canada
关键词
CTGF; Fibrosis; Hypertrophy; Arrhythmias; TISSUE GROWTH-FACTOR; CX43; EXPRESSION; TGF-BETA; CCN2; DYSFUNCTION; CONDUCTION; MYOCYTES;
D O I
10.1016/j.yjmcc.2015.09.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: One of the main contributors to maladaptive cardiac remodeling is fibrosis. Connective tissue growth factor (CTGF), a matricellular protein that is secreted into the cardiac extracellular matrix by both cardiomyocytes and fibroblasts, is often associated with development of fibrosis. However, recent studies have questioned the role of CTGF as a pro-fibrotic factor. Therefore, we aimed to investigate the effect of CTGF on cardiac fibrosis, and on functional, structural, and electrophysiological parameters in a mouse model of CTGF knockout (1(0) and chronic pressure overload. Methods and results: A new mouse model of global conditional CTGF KO induced by tamoxifen-driven deletion of CTGF, was subjected to 16 weeks of chronic pressure overload via transverse aortic constriction (TAC, control was sham surgery). CTGF KO TAC mice presented with hypertrophic hearts, and echocardiography revealed a decrease in contractility on a similar level as control TAC mice. Ex vivo epicardial mapping showed a low incidence of pacing-induced ventricular arrhythmias (2/12 in control TAC vs. 0/10 in CTGF MO TAC, n.s.) and a tendency towards recovery of the longitudinal conduction velocity of CTGF KO TAC hearts. Picrosirius Red staining on these hearts unveiled increased fibrosis at a similar level as control TAC hearts. Furthermore, genes related to fibrogenesis were also similarly upregulated in both TAC groups. Histological analysis revealed an increase in fibronectin and vimentin protein expression, a significant reduction in connexin43 (0;43) protein expression, and no difference in Na(v)1.5 expression of CTGF MO ventricles as compared with sham treated animals. Conclusion: Conditional CTGF inhibition failed to prevent TAC-induced cardiac fibrosis and hypertrophy. Additionally, no large differences were found in other parameters between CTGF MO and control TAC mice. With no profound effect of CTGF on fibrosis formation, other factors or pathways are likely responsible for fibrosis development. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:82 / 90
页数:9
相关论文
共 50 条
  • [31] Taxifolin protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload
    Guo, Haipeng
    Zhang, Xin
    Cui, Yuqian
    Zhou, Heng
    Xu, Dachun
    Shan, Tichao
    Zhang, Fan
    Guo, Yuan
    Chen, Yuguo
    Wu, Dawei
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2015, 287 (02) : 168 - 177
  • [32] Enhanced Denitrosylation Mitigates Cardiac Hypertrophy and Dysfunction During Chronic Pressure Overload
    Mori, Naohiro
    Kai, Shinichi
    Sips, Patrick
    Irie, Tomoya
    Ichinose, Fumito
    CIRCULATION, 2016, 134
  • [33] Caspase Inhibition Prevents Hypertrophy and Improves Cardiac Function with Chronic Pressure Overload
    Park, Misun
    Lee, Jung Ah
    Gao, Shumin
    Yoon, SeongHun
    Xie, Lai-Hua
    Charles, Ludny
    Leibovich, Samuel J.
    Kitsis, Richard N.
    Vatner, Stephen F.
    Vatner, Dorothy E.
    CIRCULATION, 2011, 124 (21)
  • [34] PATHOLOGY OF CARDIAC-HYPERTROPHY IN PRESSURE OVERLOAD
    TEZUKA, F
    TAKAHASHI, T
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1976, 40 (10): : 1111 - 1118
  • [35] Calcineurin regulation in pressure overload cardiac hypertrophy
    Li, J
    Guo, HY
    Takagi, G
    Hong, C
    Karoor, V
    West, M
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2003, 30 (07) : A40 - A41
  • [36] Microtubule stabilization in pressure overload cardiac hypertrophy
    Sato, H
    Nagai, T
    Kuppuswamy, D
    Narishige, T
    Koide, M
    Menick, DR
    Cooper, G
    JOURNAL OF CELL BIOLOGY, 1997, 139 (04): : 963 - 973
  • [37] MYOCARDIAL FIBROSIS IN NONHUMAN PRIMATE WITH PRESSURE OVERLOAD HYPERTROPHY
    PICK, R
    JANICKI, JS
    WEBER, KT
    AMERICAN JOURNAL OF PATHOLOGY, 1989, 135 (05): : 771 - 781
  • [38] Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice
    Harada, K
    Komuro, I
    Shiojima, I
    Hayashi, D
    Kudoh, S
    Mizuno, T
    Kijima, K
    Matsubara, H
    Sugaya, T
    Murakami, K
    Yazaki, Y
    CIRCULATION, 1998, 97 (19) : 1952 - 1959
  • [39] Rapid upregulation of CTGF in cardiac myocytes by hypertrophic stimuli: implication for cardiac fibrosis and hypertrophy
    Matsui, Y
    Sadoshima, J
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2004, 37 (02) : 477 - 481
  • [40] Stem Cell Antigen 1 Protects Against Cardiac Hypertrophy and Fibrosis After Pressure Overload
    Zhou, Heng
    Bian, Zhou-Yan
    Zong, Jing
    Deng, Wei
    Yan, Ling
    Shen, Di-Fei
    Guo, Haipeng
    Dai, Jia
    Yuan, Yuan
    Zhang, Rui
    Lin, Ya-Fen
    Hu, Xue
    Li, Hongliang
    Tang, Qi-Zhu
    HYPERTENSION, 2012, 60 (03) : 802 - +